Varenicline and the Evaluation of Neuropsychiatric Adverse Events in Smokers

被引:2
|
作者
O'Malley, Stephanie S. [1 ]
机构
[1] Yale Univ, Sch Med, Div Subst Abuse Res, New Haven, CT 06517 USA
关键词
DEPRESSION; SMOKING;
D O I
10.1016/j.biopsych.2011.04.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:1017 / 1018
页数:2
相关论文
共 50 条
  • [21] The Risk Of Cardiovascular And Neuropsychiatric Adverse Events Following Varenicline Use For Tobacco Cessation In Ontario, Canada: A Self-Controlled Study
    Gershon, A. S.
    Campitelli, M. A.
    Hawken, S.
    Victor, J. C.
    Sproule, B.
    Kurdyak, P.
    Selby, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [22] Pharmacogenetics of dolutegravir and bictegravir neuropsychiatric adverse events
    Hoffmann, Christian
    MacKay, Alice
    Schewe, Carl Knud
    Hansen, Stefan
    Buhk, Thomas
    Fenske, Stefan
    Stellbrink, Hans-Juergen
    Adam, Axel
    Sabranski, Michael
    Boffito, Marta
    Owen, Andrew
    Elliot, Emilie
    INFECTION, 2021, 49 (SUPPL 1) : S21 - S22
  • [23] Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis Reply
    Toovey, Stephen
    DRUG SAFETY, 2012, 35 (12) : 1188 - 1190
  • [24] Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine
    McCann, UD
    Eligulashvili, V
    Ricaurte, GA
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1998, 22 (07): : 1087 - 1102
  • [25] Neuropsychiatric adverse events in brodalumab psoriasis studies
    Lebwohl, Mark
    Papp, Kim A.
    Wu, Jashin
    Blauvelt, Andrew
    Menter, Alan
    Rastogi, Shipra
    Israel, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB178 - AB178
  • [26] Dolutegravir and neuropsychiatric adverse events: a continuing debate
    Cailhol, Johann
    Rouyer, Cile
    Alloui, Chakib
    Jeantils, Vincent
    AIDS, 2017, 31 (14) : 2023 - 2024
  • [27] Use of varenicline versus bupropion and risk of psychiatric adverse events
    Pasternak, Bjorn
    Svanstrom, Henrik
    Hviid, Anders
    ADDICTION, 2013, 108 (07) : 1336 - 1343
  • [28] Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System
    Meyer, Tamra E.
    Taylor, Lockwood G.
    Xie, Suji
    Graham, David J.
    Mosholder, Andrew D.
    Williams, James R.
    Moeny, David
    Ouellet-Hellstrom, Rita P.
    Coster, Trinka S.
    ADDICTION, 2013, 108 (01) : 203 - 210
  • [29] Mental health related adverse events of cytisine and varenicline in smokers with and without mental health disorders: Secondary analysis of a randomized controlled trial
    Talukder, Saki Rubaiya
    Lappin, Julia
    Boland, Veronica Clare
    Weaver, Natasha
    McRobbie, Hayden
    Courtney, Ryan James
    ADDICTIVE BEHAVIORS, 2024, 159
  • [30] Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study
    De Greef, Julien
    Yombi, Jean Cyr
    Vincent, Anne
    Vandercam, Bernard
    de Timary, Philippe
    Boland, Lidvine
    Philippeau, Magali
    Panin, Nadtha
    Elens, Laure
    Haufroid, Vincent
    Belkhir, Leila
    JOURNAL OF INFECTIOUS DISEASES, 2025,